Naloxone* recalls

The FDA has published 4 recalls involving Naloxone* since 2014. The latest was reported on 7 Jun 2023. Most were for sterility. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2014
Last 12 months0reported
Class I125% of total
Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 25%Class II 3 75%Class III 0 0%

By year

Ongoing naloxone* recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IINaloxone Injection, USP 0.4 mg/mL, For Intravenous recalled by AkornAkornPotency & AssayNationwide

All naloxone* recalls, newest first

4 total

Should you stop taking Naloxone*?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.